Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Lægefællesskabet Grenå I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   2.7% 1.6% 1.7% 1.5% 1.0% 1.6% 6.9% 6.9%   Credit score (0-100)   62 76 73 76 87 73 35 35   Credit rating   BBB A A A A A BBB BBB   Credit limit (kDKK)   0.0 10.5 5.9 41.9 432.0 14.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,109 10,780 12,465 14,322 14,996 16,183 0.0 0.0   EBITDA   3,330 2,472 3,257 4,838 3,117 3,816 0.0 0.0   EBIT   2,932 1,979 2,643 4,287 2,493 3,323 0.0 0.0   Pre-tax profit (PTP)   2,878.5 1,908.0 2,556.0 4,258.9 2,450.4 3,286.0 0.0 0.0   Net earnings   2,878.5 1,908.0 2,556.0 4,258.9 2,450.4 3,286.0 0.0 0.0   Pre-tax profit without non-rec. items   2,879 1,908 2,556 4,259 2,450 3,286 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,863 3,346 2,799 2,315 3,257 2,831 0.0 0.0   Shareholders equity total   1,337 1,254 1,471 3,743 2,892 4,173 0.0 0.0   Interest-bearing liabilities   2,567 3,783 2,466 832 1,738 3.3 932 932   Balance sheet total (assets)   5,091 6,128 5,551 5,569 5,722 5,631 932 932   Net Debt   2,488 3,628 2,391 717 1,628 -246 932 932     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,109 10,780 12,465 14,322 14,996 16,183 0.0 0.0   Gross profit growth   34.0% 6.6% 15.6% 14.9% 4.7% 7.9% -100.0% 0.0%   Employees   18 27 27 26 31 27 0 0   Employee growth %   0.0% 50.0% 0.0% -3.7% 19.2% -12.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,091 6,128 5,551 5,569 5,722 5,631 932 932   Balance sheet change%   28.0% 20.4% -9.4% 0.3% 2.7% -1.6% -83.4% 0.0%   Added value   3,330.1 2,472.2 3,256.7 4,838.0 3,043.7 3,815.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   195 311 -1,757 -1,278 1,248 -1,705 -1,033 -1,371   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   29.0% 18.4% 21.2% 29.9% 16.6% 20.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   64.7% 35.3% 45.3% 77.1% 44.2% 58.5% 0.0% 0.0%   ROI %   85.3% 43.6% 58.0% 100.7% 54.2% 75.5% 0.0% 0.0%   ROE %   250.2% 147.3% 187.6% 163.4% 73.9% 93.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   26.3% 20.5% 26.5% 67.2% 50.5% 74.1% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   74.7% 146.7% 73.4% 14.8% 52.2% -6.4% 0.0% 0.0%   Gearing %   191.9% 301.7% 167.6% 22.2% 60.1% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.3% 2.2% 2.8% 1.7% 3.3% 4.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.3 0.4 1.1 0.5 1.2 0.0 0.0   Current Ratio   0.3 0.3 0.4 1.1 0.5 1.2 0.0 0.0   Cash and cash equivalent   78.2 155.5 75.0 114.7 109.7 249.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -2,569.1 -3,386.5 -2,133.1 182.1 -1,453.1 313.1 -466.0 -466.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   185 92 121 186 98 141 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   185 92 121 186 101 141 0 0   EBIT / employee   163 73 98 165 80 123 0 0   Net earnings / employee   160 71 95 164 79 122 0 0